Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Intensity Therapeutics signs clinical collaboration agreement with Bristol Myers Squibb for advanced solid tumors

pharmaceutical-business-reviewApril 17, 2020

Tag: Bristol Myers Squibb , Solid Tumors , Intensity Therapeutics , INT230-6

PharmaSources Customer Service